ANI Pharmaceuticals ANIP
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$2.80M (9 inflow days, 11 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 32.8% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 14.90% to 15.61% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| American Century Investment Management | Mutual Fund | 2026/Q3 | +338,173 | 4.3% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +323,796 | 3.1% |
| Victory Capital Management Inc. | Mutual Fund | 2026/Q3 | +305,486 | 1.6% |
| BlackRock | Mutual Fund | 2026/Q3 | +197,219 | 14.9% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +119,323 | 4.5% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +105,285 | 3.4% |
| Ruffer LLP | Mutual Fund | 2026/Q3 | +97,161 | 0.8% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +66,483 | 4.3% |
| abrdn plc | Mutual Fund | 2026/Q3 | +62,590 | 1.6% |
| Deutsche Bank Aktiengesellschaft | Public Company | 2026/Q3 | +46,333 | 1.1% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +44,117 | 0.2% |
| American Century Investment Management | Mutual Fund | 2026/Q3 | +382,898 | 2.7% |
| Rubric Capital Management LP | Hedge Fund | 2026/Q3 | +258,131 | 1.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +211,154 | 13.8% |
| Global Alpha Capital Management Ltd. | Mutual Fund | 2026/Q3 | +196,763 | 2.6% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 12 Nov 2026 | Meredith Cook | Senior Vice President | Automatic Disposition | -500 | $70.80 | 72,924 |
| 28 Oct 2026 | Stephen Carey | Chief Financial Officer | Automatic Disposition | -2,850 | $72.87 | 166,143 |
| 14 Oct 2026 | Nikhil Lalwani | Chief Executive Officer | Automatic Disposition | -5,400 | $71.89 | 333,689 |
| 14 Oct 2026 | Nikhil Lalwani | Chief Executive Officer | Intent to Sell (Form 144) | -5,400 | $70.16 | – |
| 12 Oct 2026 | Meredith Cook | Senior Vice President | Automatic Disposition | -500 | $73.59 | 73,424 |
| 28 Sep 2026 | Stephen Carey | Chief Financial Officer | Automatic Disposition | -2,850 | $73.00 | 168,993 |
| 14 Sep 2026 | Nikhil Lalwani | Chief Executive Officer | Automatic Disposition | -5,400 | $71.00 | 339,089 |
| 13 Sep 2026 | Meredith Cook | Senior Vice President | Automatic Disposition | -500 | $70.79 | 73,924 |
| 10 Sep 2026 | Jeanne Thoma | Independent Director | Automatic Disposition | -1,000 | $71.53 | 26,762 |
| 30 Aug 2026 | Stephen Carey | Chief Financial Officer | Automatic Disposition | -2,850 | $72.80 | 171,843 |
| 24 Aug 2026 | Nikhil Lalwani | Chief Executive Officer | Automatic Disposition | -5,400 | $74.30 | 344,489 |
| 18 Aug 2026 | Henry Gosebruch | Director | Other Acquisition | +6,662 | – | 6,662 |
| 12 Aug 2026 | Meredith Cook | Senior Vice President | Automatic Disposition | -500 | $75.48 | 74,424 |
| 9 Aug 2026 | Ori Gutwerg | Senior Vice President of Generics | Open Market Disposition | -3,162 | $77.00 | 75,534 |
| 28 Jul 2026 | Stephen Carey | Chief Financial Officer | Automatic Disposition | -2,850 | $81.36 | 174,693 |
| 17 Jul 2026 | Meredith Cook | Senior Vice President | Sale to Issuer | -2,466 | $79.20 | 74,924 |
| 12 Jul 2026 | Meredith Cook | Senior Vice President | Automatic Disposition | -500 | $81.84 | 77,390 |
| 6 Jul 2026 | Patrick Walsh | Former Independent Chairperson | Intent to Sell (Form 144) | -4,336 | $86.19 | – |
| 1 Jul 2026 | Stephen Carey | Chief Financial Officer | Derivative Exercise and Sale | -3,313 | $86.00 | 177,543 |
| 28 Jun 2026 | Stephen Carey | Chief Financial Officer | Automatic Disposition | -2,850 | $84.12 | 177,543 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 3,583,674 | 15.6% | 11.9 |
| 15 Oct 2026 | 3,472,078 | 15.1% | 10.1 |
| 30 Sep 2026 | 3,491,281 | 15.2% | 7.2 |
| 15 Sep 2026 | 2,490,166 | 10.8% | 7.4 |
| 31 Aug 2026 | 3,364,919 | 14.7% | 9.2 |
| 14 Aug 2026 | 3,420,781 | 14.9% | 7.4 |
No comments yet — be the first to weigh in on ANIP.
Sign in to join the discussion.